StemCell Institute (TSE:7096) 5-Year EBITDA Growth Rate : 14.10% (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is StemCell Institute 5-Year EBITDA Growth Rate?

StemCell Institute's EBITDA per Share for the three months ended in Sep. 2024 was 円0.00.

During the past 12 months, StemCell Institute's average EBITDA Per Share Growth Rate was 4.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 61.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 14.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of StemCell Institute was 61.90% per year. The lowest was -4.50% per year. And the median was 3.40% per year.

Competitive Comparison of StemCell Institute's 5-Year EBITDA Growth Rate

For the Biotechnology subindustry, StemCell Institute's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

StemCell Institute's 5-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, StemCell Institute's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where StemCell Institute's 5-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

StemCell Institute 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

StemCell Institute (TSE:7096) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

StemCell Institute 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of StemCell Institute's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

StemCell Institute Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » StemCell Institute (TSE:7096) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Shimbashi, Minato-ku, Tamuracho Building, Matsuoka, Tokyo, JPN, 105-0004

Website

https://www.stemcell.co.jp

StemCell Institute is engaged in Cell bank business that separates and stores cord blood for regenerative medicine. Cord blood is the baby's blood contained in the umbilical cord and placenta that connects mother and baby. In its umbilical cord blood storage business, upon receiving notification from customers who have contracted, umbilical cord blood collected at obstetric facilities throughout Japan is collected, transported to the company's own cell processing center within 48 hours, and it provides a service to store cells at ultra-low temperature after separating cells from blood.

StemCell Institute Headlines

No Headlines